Answers are grounded in this paper and cite their sources.
Rabbit muscle pyruvate kinase is 90% inactivated by binding 2 to 4 moles of pyridoxal 5'-phosphate per mole of tetrameric enzyme. Incubation with pyridoxal-5'-P in 0.2 m imidazole (pH 7.5) results in a time-dependent loss of enzymatic activity which reaches a final value in 10 to 20 min at 25°. Half-maximal loss of activity occurs with 0.04 mm pyridoxal-5'-P. The inactivation is not accompanied by a gross conformational change. The inactivation is first order with respect to pyridoxal-5'-P concentration and enzyme concentration; the second order rate constant is 37 m-1 sec-1. Generally, increasing the ionic strength decreases the rate of inactivation by pyridoxal-5'-P, but low concentrations (1 to 10 mm) of divalent cations increase it above the level with no salt. The phosphate-containing metabolites, ADP, ATP, phosphoenolpyruvate, and fructose diphosphate, also decrease the rate; the effect is more pronounced in the presence of low concentrations (0.1 mm) of divalent cations. The inactivation is relatively specific for pyridoxal-5'-P, since various analogues including pyridoxamine, pyridoxamine 5-phosphate, and pyridoxal cause little or no inactivation. Reduction with NaBH4 at various concentrations of pyridoxal-5'-P shows that there are two types of binding: (a) a specific, inactivating binding, involving 2 to 4 moles of pyridoxal-5'-P bound per mole of enzyme, and (b) a nonspecific, noninactivating binding which can involve 20 or more additional moles of pyridoxal-5'-P bound per mole of enzyme. Both types involve Schiff base formation with e-NH2 groups of lysine. Reversal of the inactivation is accomplished, only with unreduced enzyme, by dilution, by dialysis, or by addition of Tris.
No takes yet. Share an insight, caveat, or question.
Johnson et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: